Leave no hit behind: accelerating lead molecule discovery against difficult targets

Leave no hit behind: accelerating lead molecule discovery against difficult targets

Thursday, April 1, 2021 2:20 PM to 2:40 PM · 20 min. (Africa/Abidjan)
Antibodies
Showcase
Presentation

Information

  •  Traditional hybridoma and phage display methods have failed to yield therapeutic antibodies against difficult targets like most GPCRs and ion channels 
  • This presentation will introduce Berkeley Lights’ new Opto™ Plasma B Discovery 4.0 workflow that enables recovery of 1000s of hits by screening up to 100,000 plasma B cells, down-selection of lead candidates by functional screening, and sequencing and re-expression of >1000 functionally-characterized antibodies … all in just 1 week 
  • By maximizing the diversity of antibodies through direct functional profiling of plasma B cells, the Opto Plasma B Discovery 4.0 workflow will allow users to tackle even the most challenging targets

John Proctor, Sr. Vice President, Antibody Therapeutics, Berkeley Lights 

Log in